“Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance”. 2026. International Journal of Emerging Research in Applied Medical Sciences 2 (4): 10-18. https://doi.org/10.65477/j29hcv64.